Clinical trial NCT05299333: Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis
Official title: Comparison of the Effectiveness of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Pulmonary Fibrosis Due to COVID-19
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: COVID-19
Pulmonary Fibrosis
Keywords: Post covid fibrosis
Pulmonary Rehabilitation
Physical Activity
Lead sponsor: Istanbul University - Cerrahpasa
Sponsor class: OTHER
Collaborators: name: Health Institutes of Turkey
First posted: 2022-03-29
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Rehabilitation plays a very important role in the management of patients with COVID-19, focusing on respiratory and motor functions, and therefore the importance of establishing treatment strategies to ensure optimal recovery of these patients has been emphasized. It has been stated that physical activity recommendations should be clarified for the management of symptoms associated with prolonged COVID-19 Syndrome and for the continuation of activities of daily living. It has been stated that after COVID-19 pneumonia, it is necessary to evaluate the physical functions of patients with long-term follow-up and to establish rehabilitation programs. The importance of being included in the rehabilitation program was emphasized, especially for patients with lung fibrosis.

The primary aim of this study was to compare the effects of pulmonary telerehabilitation and physical activity recommendations on exercise capacity and peripheral muscle strength in patients with pulmonary fibrosis due to COVID-19.

The secondary aim of this study is to compare the effects of pulmonary telerehabilitation and physical activity recommendations on symptoms, activity and participation in patients with pulmonary fibrosis due to COVID-19.


Eligibility criteria: Inclusion Criteria:

* \>18 years old
* Patients who have been infected with the COVID-19 virus at least three months ago and have been diagnosed with a positive PCR
* Patients with post-COVID-19 pulmonary fibrosis followed by a pulmonologist
* Patients who have sufficient technological infrastructure to participate in the telerehabilitation program and can adapt to online systems
* Patients who are clinically stable

Exclusion Criteria:

* Patients with orthopedic/neurological problems that prevent walking and exercise
* Patients with uncontrolled cardiovascular disease
* Patients with uncontrolled medical conditions

Primary outcomes:
measure: Submaximal exercise capacity
timeFrame: 1 week-8 week
measure: maximal exercise capacity
timeFrame: 1 week-8 week
measure: endurance exercise capacity
timeFrame: 1 week-8 week
measure: Peripheral muscle strength
timeFrame: 1 week-8 week
Secondary outcomes:
measure: Physical activity
timeFrame: 1 week-8 week
measure: Dyspnea
timeFrame: 1 week-8 week
measure: Fatigue
timeFrame: 1 week-8 week
measure: Physical fitness
timeFrame: 1 week-8 week
measure: Functionality
timeFrame: 1 week-8 week
measure: System usability
timeFrame: 8 week
measure: Emotional status
timeFrame: 1 week-8 week
measure: Body composition
timeFrame: 1 week-8 week
measure: Activities of daily living
timeFrame: 1 week-8 week
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul University-Cerrahpasa
Study officials:
References: